☰

Sarah L. Kerns, Ph.D. - Publications

Affiliations: 
2007 Northwestern University, Evanston, IL 
Area:
Molecular Biology, Cell Biology
Tree Info Grants Similar researchers PubMed Report error

62 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Oh JH, Lee S, Thor M, Rosenstein BS, Tannenbaum A, Kerns S, Deasy JO. Predicting the germline dependence of hematuria risk in prostate cancer radiotherapy patients. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 185: 109723. PMID 37244355 DOI: 10.1016/j.radonc.2023.109723  0.329
2020 Massi MC, Gasperoni F, Ieva F, Paganoni AM, Zunino P, Manzoni A, Franco NR, Veldeman L, Ost P, Fonteyne V, Talbot CJ, Rattay T, Webb A, Symonds PR, Johnson K, ... ... Kerns SL, et al. A Deep Learning Approach Validates Genetic Risk Factors for Late Toxicity After Prostate Cancer Radiotherapy in a REQUITE Multi-National Cohort. Frontiers in Oncology. 10: 541281. PMID 33178576 DOI: 10.3389/fonc.2020.541281  0.315
2020 Collado K, Kerns SL, Diefenbach MA, Peterson-Roth E, Koski R, Ostrer H, Stock RG, Mattessich M, Kaplan P, Rosenstein BS. Survey of Radiation Oncologists to Assess Interest and Potential Use of a Genetic Test Predicting Susceptibility for the Development of Toxicities After Prostate Cancer Radiation Therapy. Advances in Radiation Oncology. 5: 897-904. PMID 33083651 DOI: 10.1016/J.Adro.2020.03.019  0.387
2020 Marples B, Kerns S. Oncology Scan: Radiation Biology and Genomic Predictors of Response. International Journal of Radiation Oncology, Biology, Physics. 107: 393-397. PMID 32531379 DOI: 10.1016/J.Ijrobp.2020.04.008  0.321
2019 Bergom C, West CM, Higginson DS, Abazeed ME, Arun B, Bentzen SM, Bernstein JL, Evans JD, Gerber NK, Kerns SL, Keen J, Litton JK, Reiner AS, Riaz N, Rosenstein BS, et al. The implications of genetic testing on radiotherapy decisions: a guide for radiation oncologists. International Journal of Radiation Oncology, Biology, Physics. PMID 31381960 DOI: 10.1016/J.Ijrobp.2019.07.026  0.342
2019 Kerns SL, Fachal L, Dorling L, Barnett GC, Baran A, Peterson DR, Hollenberg M, Hao K, Narzo AD, Ahsen ME, Pandey G, Bentzen SM, Janelsins M, Elliott RM, Pharoah PDP, et al. Radiogenomics Consortium Genome-Wide Association Study Meta-analysis of Late Toxicity after Prostate Cancer Radiotherapy. Journal of the National Cancer Institute. PMID 31095341 DOI: 10.1093/Jnci/Djz075  0.432
2019 Yao S, Hu Q, Kerns S, Yan L, Onitilo AA, Misleh J, Young K, Lei L, Bautista J, Mohamed M, Mohile SG, Ambrosone CB, Liu S, Janelsins MC. Impact of chemotherapy for breast cancer on leukocyte DNA methylation landscape and cognitive function: a prospective study. Clinical Epigenetics. 11: 45. PMID 30867049 DOI: 10.1186/S13148-019-0641-1  0.315
2019 Schumacher FR, Olama AAA, Berndt SI, Benlloch S, Ahmed M, Saunders EJ, Dadaev T, Leongamornlert D, Anokian E, Cieza-Borrella C, Goh C, Brook MN, Sheng X, Fachal L, Dennis J, ... ... Kerns SL, et al. Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci. Nature Genetics. PMID 30622367 DOI: 10.1038/S41588-018-0330-6  0.32
2019 West C, Kerns S, Dorling L, Barnett G, Dearnaley D, Fachal L, Veldeman L, Parliament M, Vega A, Dunning A, Rosenstein B. OC-0374 GWAS identifies new susceptibility loci for late toxicity following prostate cancer radiotherapy Radiotherapy and Oncology. 133: S186. DOI: 10.1016/S0167-8140(19)30794-7  0.388
2019 Hall W, Baran A, Peterson D, Bergom C, Lawton C, Zhang H, Bylund K, Messing E, Chen Y, Morrow G, Kerns S. Characterization of the Host Immuno-Inflammatory State in Response to Radiation Therapy and Correlation with Patient Reported Toxicities In Prostate Adenocarcinoma, A Prospective Observational Trial International Journal of Radiation Oncology*Biology*Physics. 105: S114-S115. DOI: 10.1016/J.Ijrobp.2019.06.613  0.337
2019 Kang J, Strawderman R, Dearnaley D, Hall E, Burnet N, West C, Kerns S. Predicting Prostate Radiotherapy Toxicity in a Phase III Trial Using Clinical/Dosimetric Variables in Logistic Regression and Random Forest Models International Journal of Radiation Oncology*Biology*Physics. 105: E285. DOI: 10.1016/J.Ijrobp.2019.06.1820  0.302
2018 Kang J, Rancati T, Lee S, Oh JH, Kerns SL, Scott JG, Schwartz R, Kim S, Rosenstein BS. Machine Learning and Radiogenomics: Lessons Learned and Future Directions. Frontiers in Oncology. 8: 228. PMID 29977864 DOI: 10.3389/Fonc.2018.00228  0.349
2018 Dadaev T, Saunders EJ, Newcombe PJ, Anokian E, Leongamornlert DA, Brook MN, Cieza-Borrella C, Mijuskovic M, Wakerell S, Olama AAA, Schumacher FR, Berndt SI, Benlloch S, Ahmed M, Goh C, ... ... Kerns S, et al. Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants. Nature Communications. 9: 2256. PMID 29892050 DOI: 10.1038/S41467-018-04109-8  0.393
2018 Schumacher FR, Al Olama AA, Berndt SI, Benlloch S, Ahmed M, Saunders EJ, Dadaev T, Leongamornlert D, Anokian E, Cieza-Borrella C, Goh C, Brook MN, Sheng X, Fachal L, Dennis J, ... ... Kerns SL, et al. Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci. Nature Genetics. PMID 29892016 DOI: 10.1038/S41588-018-0142-8  0.364
2018 Kerns S, Chuang KH, Hall W, Werner Z, Chen Y, Ostrer H, West C, Rosenstein B. Radiation biology and oncology in the genomic era. The British Journal of Radiology. 20170949. PMID 29888979 DOI: 10.1259/Bjr.20170949  0.399
2018 Kerns SL, Fung C, Monahan PO, Ardeshir-Rouhani-Fard S, Abu Zaid MI, Williams AM, Stump TE, Sesso HD, Feldman DR, Hamilton RJ, Vaughn DJ, Beard C, Huddart RA, Kim J, Kollmannsberger C, et al. Cumulative Burden of Morbidity Among Testicular Cancer Survivors After Standard Cisplatin-Based Chemotherapy: A Multi-Institutional Study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2017770735. PMID 29617189 DOI: 10.1200/Jco.2017.77.0735  0.304
2018 Lee S, Kerns S, Ostrer H, Rosenstein B, Deasy JO, Oh JH. Machine Learning on a Genome-wide Association Study to Predict Late Genitourinary Toxicity After Prostate Radiation Therapy. International Journal of Radiation Oncology, Biology, Physics. PMID 29502932 DOI: 10.1016/J.Ijrobp.2018.01.054  0.446
2018 Termer NK, Richardson M, Adams MJ, Alongi A, Bellohusen P, Bruckner LB, Cowen R, Fritsch S, Hettler D, Kerns SL, Pandya C, Williams A, Constine LS. Meeting requirements for survivorship visits: Interventions for patient identification. Journal of Clinical Oncology. 36: 59-59. DOI: 10.1200/Jco.2018.36.7_Suppl.59  0.305
2018 Lee S, Oh J, Kerns S, Rosenstein B, Ostrer H, Deasy J. PV-0564: Predicting Genitourinary Toxicity by Machine Learning on Genome-Wide Single Nucleotide Polymorphisms Radiotherapy and Oncology. 127: S297-S298. DOI: 10.1016/S0167-8140(18)30874-0  0.302
2018 Kerns S, Fachal L, Dorling L, Barnett G, Burnet N, Sydes M, Dearnaley D, Dunning A, Pharoah P, Parliament M, Usmani N, de Ruyck K, Ostrer H, Rosenstein B, CaamaNo AG, et al. Meta-Analysis of Genome-Wide Association Studies (GWAS) of Late Toxicity in 3,874 Men Treated with Radiation for Prostate Cancer International Journal of Radiation Oncology*Biology*Physics. 102: e738-e739. DOI: 10.1016/J.Ijrobp.2018.07.1976  0.427
2017 El Naqa I, Kerns SL, Coates J, Luo Y, Speers C, West CML, Rosenstein BS, Ten Haken RK. Radiogenomics and radiotherapy response modeling. Physics in Medicine and Biology. PMID 28657906 DOI: 10.1088/1361-6560/Aa7C55  0.304
2017 Azria D, Lapierre A, Gourgou S, De Ruysscher D, Colinge J, Lambin P, Brengues M, Ward T, Bentzen SM, Thierens H, Rancati T, Talbot CJ, Vega A, Kerns SL, Andreassen CN, et al. Data-Based Radiation Oncology: Design of Clinical Trials in the Toxicity Biomarkers Era. Frontiers in Oncology. 7: 83. PMID 28497027 DOI: 10.3389/Fonc.2017.00083  0.33
2017 Fung C, Sesso HD, Williams AM, Kerns SL, Monahan P, Abu Zaid M, Feldman DR, Hamilton RJ, Vaughn DJ, Beard CJ, Kollmannsberger CK, Cook R, Althouse S, Ardeshir-Rouhani-Fard S, Lipshultz SE, et al. Multi-Institutional Assessment of Adverse Health Outcomes Among North American Testicular Cancer Survivors After Modern Cisplatin-Based Chemotherapy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2016703108. PMID 28240972 DOI: 10.1200/Jco.2016.70.3108  0.302
2017 Oh JH, Kerns S, Ostrer H, Powell SN, Rosenstein B, Deasy JO. Computational methods using genome-wide association studies to predict radiotherapy complications and to identify correlative molecular processes. Scientific Reports. 7: 43381. PMID 28233873 DOI: 10.1038/Srep43381  0.393
2017 Cole CL, Kleckner I, Kerns S, Asare M, Lin P, Kamen C, Janelsins M, Mustian K. Feasibility of Exercise for Improving Inflammation in Advance Stage Prostate Cancer Patients Medicine & Science in Sports & Exercise. 49: 270. DOI: 10.1249/01.Mss.0000517595.63003.0A  0.324
2017 Kerns SL, Fung C, Williams A, Zaid MIA, Sesso HD, Monahan P, Ardeshirrouhanifard S, Feldman DR, Hamilton RJ, Vaughn DJ, Beard C, Huddart RA, Kim J, Kollmannsberger CK, Sahasrabudhe DM, et al. Clinical, sociodemographic, and behavioral factors associated with cumulative burden of morbidity (CBM) among testicular cancer survivors (TCS) in the Platinum study. Journal of Clinical Oncology. 35: 10075-10075. DOI: 10.1200/Jco.2017.35.15_Suppl.10075  0.325
2017 Kerns S, Hao K, Stahl E, Rosenstein B, CaamaNo AG, Carballo A, Peleteiro P, Fachal L, Vega A, Dunning A, Sydes M, Hall E, Dearnaley D, West C, Ostrer H. Contribution of Common SNPs to Variability in Late Radiation Therapy Toxicity in Prostate Cancer International Journal of Radiation Oncology*Biology*Physics. 99: E601. DOI: 10.1016/J.Ijrobp.2017.06.2047  0.406
2016 Oh J, Kerns S, Ostrer H, Rosenstein B, Deasy J. SU-D-204-06: Integration of Machine Learning and Bioinformatics Methods to Analyze Genome-Wide Association Study Data for Rectal Bleeding and Erectile Dysfunction Following Radiotherapy in Prostate Cancer. Medical Physics. 43: 3333. PMID 28046236 DOI: 10.1118/1.4955611  0.409
2016 Kerns SL, Dorling L, Fachal L, Bentzen S, Pharoah PD, Barnes DR, Gómez-Caamaño A, Carballo AM, Dearnaley DP, Peleteiro P, Gulliford SL, Hall E, Michailidou K, Carracedo Á, Sia M, et al. Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer. Ebiomedicine. PMID 27515689 DOI: 10.1016/J.Ebiom.2016.07.022  0.449
2016 Andreassen CN, Rosenstein BS, Kerns SL, Ostrer H, De Ruysscher D, Cesaretti JA, Barnett GC, Dunning AM, Dorling L, West CM, Burnet NG, Elliott R, Coles C, Hall E, Fachal L, et al. Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 27443449 DOI: 10.1016/J.Radonc.2016.06.017  0.374
2016 Ahmed M, Dorling L, Kerns S, Fachal L, Elliott R, Partliament M, Rosenstein BS, Vega A, Gómez-Caamaño A, Barnett G, Dearnaley DP, Hall E, Sydes M, Burnet N, Pharoah PD, et al. Common genetic variation associated with increased susceptibility to prostate cancer does not increase risk of radiotherapy toxicity. British Journal of Cancer. PMID 27070714 DOI: 10.1038/Bjc.2016.94  0.418
2016 Baijer J, Déchamps N, Perdry H, Morales P, Kerns S, Vasilescu A, Baulande S, Azria D, Roméo PH, Schmitz A. TNFSF10/TRAIL regulates human T4 effector memory lymphocyte radiosensitivity and predicts radiation-induced acute and subacute dermatitis. Oncotarget. PMID 26982083 DOI: 10.18632/Oncotarget.7893  0.335
2016 Herskind C, Talbot CJ, Kerns SL, Veldwijk MR, Rosenstein BS, West CM. Radiogenomics: A systems biology approach to understanding genetic risk factors for radiotherapy toxicity? Cancer Letters. PMID 26944314 DOI: 10.1016/J.Canlet.2016.02.035  0.342
2016 Kerns SL, Fung C, Williams A, Zaid MIA, Sesso HD, Monahan P, Ardeshir-Rouhani-Fard S, Feldman DR, Hamilton RJ, Vaughn DJ, Beard C, Sahasrabudhe DM, Fossa SD, Einhorn LH, Travis LB. Cumulative burden of morbidity (CBM) among testicular cancer survivors (TCS) in the Platinum study. Journal of Clinical Oncology. 34: 10089-10089. DOI: 10.1200/Jco.2016.34.15_Suppl.10089  0.316
2016 Oh J, Kerns S, Ostrer H, Rosenstein B, Deasy J. EP-2058: A novel multi-SNP model predictive of erectile dysfunction following radiotherapy in prostate cancer Radiotherapy and Oncology. 119: S971. DOI: 10.1016/S0167-8140(16)33309-6  0.379
2015 Bourgier C, Kerns S, Gourgou S, Lemanski C, Gutowski M, Fenoglietto P, Romieu G, Crompton N, Lacombe J, Pèlegrin A, Ozsahin M, Rosenstein B, Azria D. Concurrent or sequential letrozole with adjuvant breast radiotherapy: Final results of the CO-HO-RT phase II randomized trial. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. PMID 26681684 DOI: 10.1093/Annonc/Mdv602  0.34
2015 Kerns SL, Kundu S, Oh JH, Singhal SK, Janelsins M, Travis LB, Deasy JO, Janssens AC, Ostrer H, Parliament M, Usmani N, Rosenstein BS. The Prediction of Radiotherapy Toxicity Using Single Nucleotide Polymorphism-Based Models: A Step Toward Prevention. Seminars in Radiation Oncology. 25: 281-91. PMID 26384276 DOI: 10.1016/J.Semradonc.2015.05.006  0.385
2015 Barnett GC, Kerns SL, Noble DJ, Dunning AM, West CM, Burnet NG. Incorporating Genetic Biomarkers into Predictive Models of Normal Tissue Toxicity. Clinical Oncology (Royal College of Radiologists (Great Britain)). 27: 579-87. PMID 26166774 DOI: 10.1016/J.Clon.2015.06.013  0.354
2015 Seibold P, Behrens S, Schmezer P, Helmbold I, Barnett G, Coles C, Yarnold J, Talbot CJ, Imai T, Azria D, Koch CA, Dunning AM, Burnet N, Bliss JM, Symonds RP, ... ... Kerns SL, et al. XRCC1 Polymorphism Associated With Late Toxicity After Radiation Therapy in Breast Cancer Patients. International Journal of Radiation Oncology, Biology, Physics. 92: 1084-92. PMID 26072091 DOI: 10.1016/J.Ijrobp.2015.04.011  0.37
2014 Kerns SL, West CM, Andreassen CN, Barnett GC, Bentzen SM, Burnet NG, Dekker A, De Ruysscher D, Dunning A, Parliament M, Talbot C, Vega A, Rosenstein BS. Radiogenomics: the search for genetic predictors of radiotherapy response. Future Oncology (London, England). 10: 2391-406. PMID 25525847 DOI: 10.2217/Fon.14.173  0.358
2014 Fachal L, Gómez-Caamaño A, Barnett GC, Peleteiro P, Carballo AM, Calvo-Crespo P, Kerns SL, Sánchez-García M, Lobato-Busto R, Dorling L, Elliott RM, Dearnaley DP, Sydes MR, Hall E, Burnet NG, et al. A three-stage genome-wide association study identifies a susceptibility locus for late radiotherapy toxicity at 2q24.1. Nature Genetics. 46: 891-4. PMID 24974847 DOI: 10.1038/Ng.3020  0.413
2014 Barnett GC, Thompson D, Fachal L, Kerns S, Talbot C, Elliott RM, Dorling L, Coles CE, Dearnaley DP, Rosenstein BS, Vega A, Symonds P, Yarnold J, Baynes C, Michailidou K, et al. A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 111: 178-85. PMID 24785509 DOI: 10.1016/J.Radonc.2014.02.012  0.359
2014 Kerns SL, Ostrer H, Rosenstein BS. Radiogenomics: using genetics to identify cancer patients at risk for development of adverse effects following radiotherapy. Cancer Discovery. 4: 155-65. PMID 24441285 DOI: 10.1158/2159-8290.Cd-13-0197  0.397
2014 Andreassen C, Barnett G, Kerns S, Vega A, Talbot C, De Ruyck K, Parliament M, Koch C, Gutiérrez-Enríquez S, Alsner J. OC-0143: Analysis of 5434 patients shows a link between the ATM codon 1853 SNP and the risk of radiation-induced toxicity Radiotherapy and Oncology. 111: S55-S56. DOI: 10.1016/S0167-8140(15)30248-6  0.363
2014 Kerns S, Barnett G, Dorling L, Fachal L, Burnet N, Ostrer H, Parliament M, Rosenstein B, Vega A, West C. OC-0142: Radiogenomics consortium meta-analysis of genome wide association studies of prostate radiotherapy late toxicity Radiotherapy and Oncology. 111: S55. DOI: 10.1016/S0167-8140(15)30247-4  0.381
2014 Fachal L, Gomez-Caamaño A, Barnett G, Kerns S, Rosenstein B, West C, Dunning A, Vega A, Rapper. OC-0054: A three stage genome wide association study reveals susceptibility for late radiotherapy toxicity at the 2q24 locus Radiotherapy and Oncology. 111. DOI: 10.1016/S0167-8140(15)30159-6  0.325
2014 Andreassen C, Kerns S, Rosenstein B, Barnett G, Fachal L, Vega A, Talbot C, De Ruyck K, Parliament M, Koch A, Gutiérrez-Enríquez S, Chang-Claude J, Yarnold J, Bentzen S, Elliott R, et al. Possession of the ATM Codon 1853 SNP is Associated With an Increased Risk for Radiation-Induced Toxicity International Journal of Radiation Oncology*Biology*Physics. 90: S148-S149. DOI: 10.1016/J.Ijrobp.2014.05.622  0.357
2014 Fachal L, Gomez-Caamaño A, Barnett G, Kerns S, Rosenstein B, West C, Dunning A, Vega A. Identification of a Locus at 2q24 Associated With Susceptibility for Late Radiation Therapy Toxicity Through Performance of a 3-Stage Genome-Wide Association Study International Journal of Radiation Oncology*Biology*Physics. 90: S55-S56. DOI: 10.1016/J.Ijrobp.2014.05.196  0.356
2014 Kerns S, Barnett G, Dorling L, Faschal L, Burnet N, Dunning A, Gómez-Caamaño A, Ostrer H, Parliament M, Pharoah P, Stock R, Stone N, Vega A, West C, Rosenstein B. Identification of Single Nucleotide Polymorphisms (SNPs) Associated With Late Toxicity Following Radiation Therapy for Prostate Cancer Through a Meta-Analysis of Genome-Wide Association Studies (GWAS) International Journal of Radiation Oncology*Biology*Physics. 90: S55. DOI: 10.1016/J.Ijrobp.2014.05.195  0.332
2013 Kerns SL, Stock RG, Stone NN, Blacksburg SR, Rath L, Vega A, Fachal L, Gómez-Caamaño A, De Ruysscher D, Lammering G, Parliament M, Blackshaw M, Sia M, Cesaretti J, Terk M, et al. Genome-wide association study identifies a region on chromosome 11q14.3 associated with late rectal bleeding following radiation therapy for prostate cancer. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 107: 372-6. PMID 23719583 DOI: 10.1016/J.Radonc.2013.05.001  0.418
2013 Kerns SL, Stone NN, Stock RG, Rath L, Ostrer H, Rosenstein BS. A 2-stage genome-wide association study to identify single nucleotide polymorphisms associated with development of urinary symptoms after radiotherapy for prostate cancer. The Journal of Urology. 190: 102-8. PMID 23376709 DOI: 10.1016/J.Juro.2013.01.096  0.395
2013 Buckstein M, Kerns S, Forysthe K, Stone NN, Stock RG. Temporal patterns of selected late toxicities in patients treated with brachytherapy or brachytherapy plus external beam radiation for prostate adenocarcinoma. Bju International. 111: E43-7. PMID 23046084 DOI: 10.1111/J.1464-410X.2012.11436.X  0.369
2013 Kerns SL, Stock R, Stone N, Buckstein M, Shao Y, Campbell C, Rath L, De Ruysscher D, Lammering G, Hixson R, Cesaretti J, Terk M, Ostrer H, Rosenstein BS. A 2-stage genome-wide association study to identify single nucleotide polymorphisms associated with development of erectile dysfunction following radiation therapy for prostate cancer. International Journal of Radiation Oncology, Biology, Physics. 85: e21-8. PMID 23021708 DOI: 10.1016/J.Ijrobp.2012.08.003  0.434
2013 Blacksburg S, Kerns S, Stone N, Stock R. Predicting Long-term Disease State Outcomes in Patients With Prostate Cancer Treated With Definitive Radiation International Journal of Radiation Oncology*Biology*Physics. 87: S369-S370. DOI: 10.1016/J.Ijrobp.2013.06.970  0.353
2012 Barnett GC, Elliott RM, Alsner J, Andreassen CN, Abdelhay O, Burnet NG, Chang-Claude J, Coles CE, Gutiérrez-Enríquez S, Fuentes-Raspall MJ, Alonso-Muñoz MC, Kerns S, Raabe A, Symonds RP, Seibold P, et al. Individual patient data meta-analysis shows no association between the SNP rs1800469 in TGFB and late radiotherapy toxicity. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 105: 289-95. PMID 23199655 DOI: 10.1016/J.Radonc.2012.10.017  0.334
2012 Kerns SL, Schultz KM, Barry KA, Thorne TM, McGarry TJ. Geminin is required for zygotic gene expression at the Xenopus mid-blastula transition. Plos One. 7: e38009. PMID 22662261 DOI: 10.1371/Journal.Pone.0038009  0.617
2012 Parliament M, Broadhurst D, Ghosh S, Zhu G, Kerns S, Rosenstein B, Khitrov G, Ostrer H, Warkentin B, Murray D. Single-Nucleotide Polymorphisms (SNPs) Associated With Radiation Proctitis From Genome-wide False Discovery Rate Analysis International Journal of Radiation Oncology*Biology*Physics. 84: S712-S713. DOI: 10.1016/J.Ijrobp.2012.07.1907  0.342
2012 Kerns S, Stock R, Stone N, Rath L, Ostrer H, Rosenstein B. Genome Wide Association Study to Identify Genetic Variants Associated With Urinary Symptoms Following Radiation Therapy for Prostate Cancer International Journal of Radiation Oncology*Biology*Physics. 84: S401-S402. DOI: 10.1016/J.Ijrobp.2012.07.1060  0.414
2011 Kerns S, Stone N, Stock R, Shao Y, Ostrer H, Rosenstein B. 344 GENETIC FACTORS INFLUENCE TIME TO UNDETECTABLE PSA IN MEN WITH PROSTATE CANCER TREATED BY RADIOTHERAPY Journal of Urology. 185. DOI: 10.1016/J.Juro.2011.02.428  0.358
2010 Kerns SL, Ostrer H, Stock R, Li W, Moore J, Pearlman A, Campbell C, Shao Y, Stone N, Kusnetz L, Rosenstein BS. Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer. International Journal of Radiation Oncology, Biology, Physics. 78: 1292-300. PMID 20932654 DOI: 10.1016/J.Ijrobp.2010.07.036  0.412
2007 Kerns SL, Torke SJ, Benjamin JM, McGarry TJ. Geminin prevents rereplication during xenopus development. The Journal of Biological Chemistry. 282: 5514-21. PMID 17179155 DOI: 10.1074/Jbc.M609289200  0.621
2007 Kerns SL, Torke SJ, Benjamin JM, McGarry TJ. Geminin prevents rereplication during Xenopus development Journal of Biological Chemistry. 282: 5514-5521. DOI: 10.1074/jbc.M609289200  0.604
Show low-probability matches.